logo

Mergers & Acquisitions

Share

Multinational cannabis company Clever Leaves International Inc. intends to list on Nasdaq through a merger with Schultze Special Purpose Acquisition Corp. (SAMA, SAMAW, and SAMAU). Schultze Special Purpose Acquisition or SAMA and Clever Leaves said they have signed a letter of intent or LOI to enter...

Medical technology company Haemonetics Corp. (HAE) announced Wednesday that it has entered into a definitive agreement to sell its Fajardo, Puerto Rico, manufacturing operations to Italy-based GVS S.p.A, a leading provider of advanced filtration solutions for critical applications. Under the terms...

W.W. Grainger, Inc. (GWW), a broad line supplier of maintenance, repair and operating or MRO products, said Tuesday it has agreed to sell Fabory Group to Dutch private equity firm Torqx Capital Partners. Financial terms of the transaction were not disclosed. However, the transaction is not subject...

Aduro Biotech, Inc. (ADRO) has agreed to acquire all of the outstanding capital stock of Chinook Therapeutics, Inc. in exchange for shares of Aduro common stock representing approximately 50 percent of Aduro's outstanding common stock. Chinook Therapeutics is a privately held clinical-stage biotechnology...

French grocery retailer Carrefour Group (CRERF, CRRFY, 0NPH.L) Tuesday said it has agreed to acquire Wellcome Taiwan from Dairy Farm for 97 million euros in enterprise value. The deal involves 224 proximity stores in quality locations as well as a warehouse, including ownership of the real estate...

Interactive entertainment company Zynga, Inc. agreed Monday to acquire Istanbul-based mobile gaming company Peak for $1.8 billion, comprised of approximately $900 million in cash and approximately $900 million of Zynga common stock. Peak is the creator of top charting mobile franchises Toon Blast and...

Coty Inc. (COTY) announced Monday the signing of a definitive agreement with KKR as part of a strategic transformation that will deleverage its balance sheet, streamline its operations and strengthen its leadership team. Under the definitive agreement, Coty and KKR have entered into a strategic transaction...

Capital & Counties Properties Plc or Capco (CAPC.L) announced that it has agreed to acquire a 26.3 percent shareholding in Shaftesbury PLC (SHB.L). The acquisition will be across two tranches for total consideration of 436 million pounds, at a price of 540 pence per Shaftesbury share. The per share...

Cresco Labs Inc., a multi-state cannabis operator, said it has entered into agreements with Verdant Creations, LLC that will provide it the option to purchase four additional medical marijuana dispensaries in Ohio currently operated by Verdant. Cresco will pay $375,000 in cash and $500,000 of its...

French building materials company Saint-Gobain (CODGF.PK) announced Wednesday the successful completion of the sale by its subsidiary Schenker-Winkler Holding AG of approximately 15.2 million Sika shares, representing its full stake of 10.75% of Sika's share capital, for a total of CHF 2.56 billion,...

Swiss chocolate and cocoa products company Barry Callebaut Group (BYCBF.PK) announced Wednesday that it has signed an agreement to acquire GKC Foods (Australia) Pty Ltd. The companies did not disclose any financial details of the deal. The transaction is subject to regulatory approval and other closing...

Torstar Corp. (TS.B.TO) announced it has entered into an arrangement agreement to be acquired by NordStar Capital LP. Upon completion of the transaction, Torstar will be taken private. Under the deal terms, NordStar, controlled by Jordan Bitove and Paul Rivett and wholly-owned by the Bitove and Rivett...

merck 052620 Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.

Merck & Co., Inc. (MRK) agreed to buy privately-held Themis for an undisclosed cash payment. Themis is a company focused on vaccines and immune-modulation therapies for infectious diseases and cancer. In March, Themis joined a consortium together with the Institut Pasteur and The Center for Vaccine...

Follow RTT